Prospective Biological Study to Evaluate the Persistence of COVID-19 Vaccine and Other Vaccines ' -Induced Immune Responses in Follicular Lymphoma Patients Undergoing Frontline Induction Immuno-chemotherapy and Anti-CD20 Maintenance
Conditions: Follicular Lymphoma Interventions: Diagnostic Test: Cellular immunity vs SARS-CoV-2; Diagnostic Test: Humoral immunity vs SARS-CoV-2; Diagnostic Test: Cellular immunity vs Varicella Zoster Virus; Diagnostic Test: Humoral immunity vs Varicella Zoster Virus; Diagnostic Test: Diphtheria toxin-binding IgG; Diagnostic Test: Tetanus toxoid-binding IgG; Diagnostic Test: T-cell populations and markers characterization Sponsors: Fondazione Italiana Linfomi - ETS Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Chemotherapy | Covid Vaccine | COVID-19 | Diphtheria | Lymphoma | Research | SARS | Study | Tetanus | Tetanus Vaccine | Vaccines | Varicella-Zoster Virus Vaccine